News
ICER will preempt the next Medicare drug pricing round with a 'special report' on two COPD drugs from GSK.
2d
Sand and Snow on MSNBreathe Drops Reflect Growing Interest in Non-Pharmaceutical Respiratory ProductsThe reasons behind a surge of interest in natural, non-pharmaceutical lung support solutions in 2025. What Breathe Drops are and how this liquid supplement supports healthy lung f ...
Pharmaceutical giant Merck is buying Verona Pharma, a company that concentrates its efforts on respiratory diseases, in an ...
Verona Pharma's flagship drug last year became the first new maintenance treatment for chronic obstructive pulmonary disease ...
Verona Pharma has blockbuster hopes for its recently approved drug for chronic obstructive pulmonary disorder (COPD), and preliminary sales figures for the drug suggest it is heading in the right ...
After the Veterans Health Administration tweaked its formulary on an asthma and chronic obstructive pulmonary disease therapy, hospitalizations and emergency department visits increased, according to ...
Medical news, education and information for physicians and health care professionals, presented by specialty and topic. From Healio and the Wyanoke Group.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results